TransMedics Group, Inc. (TMDX)

TMDX Balance Sheet

Assets, liabilities, and equity analysis

TMDX Quarterly Balance Sheet (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Total Current Assets	619.280M	619.280M	637.783M	612.996M	558.129M	505.918M	497.216M	492.475M	509.265M
Cash & Cash Equivalents	461.739M	461.739M	488.366M	466.174M	400.575M	310.143M	336.650M	330.094M	362.751M
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	461.739M	461.739M	488.366M	466.174M	400.575M	310.143M	336.650M	330.094M	362.751M
Accounts Receivable	90.727M	90.727M	84.282M	80.702M	104.851M	142.026M	97.722M	90.128M	81.158M
Inventory	49.890M	49.890M	48.881M	44.506M	38.868M	43.380M	46.554M	52.152M	48.671M
Total Assets	1.435B	1.435B	1.068B	946.032M	890.522M	837.530M	804.076M	785.571M	758.577M
Property, Plant & Equipment	700.974M	700.974M	332.811M	318.762M	318.073M	317.251M	292.451M	278.682M	234.926M
Goodwill	11.549M	11.549M	11.549M	11.549M	11.549M	11.549M	11.549M	11.549M	11.549M
Intangible Assets	0.00	0.00	1.948M	1.999M	2.050M	2.101M	2.152M	2.202M	2.253M
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	500K
Total Current Liabilities	91.920M	91.920M	89.305M	79.721M	56.620M	55.603M	59.913M	60.048M	54.329M
Accounts Payable	11.151M	11.151M	10.350M	12.162M	9.539M	10.595M	10.292M	13.134M	13.027M
Short-Term Debt	18.508M	18.508M	13.310M	5.000M	0.00	0.00	2.727M	2.543M	2.139M
Total Liabilities	940.813M	940.813M	595.273M	590.832M	572.421M	571.222M	575.473M	575.651M	568.683M
Long-Term Debt	498.195M	498.195M	456.381M	506.685M	510.889M	510.098M	509.311M	508.531M	507.751M
Total Debt	863.415M	863.415M	469.691M	519.349M	518.822M	518.410M	518.287M	518.146M	516.493M
Net Debt (Cash)	401.676M	401.676M	-18.675M	53.175M	118.247M	208.267M	181.637M	188.052M	153.742M
Total Shareholders' Equity	494.007M	494.007M	473.100M	355.200M	318.101M	266.308M	228.603M	209.920M	189.894M
Common Stock	764.640M	764.640M	750.926M	738.432M	725.655M	709.194M	697.208M	685.251M	669.445M
Retained Earnings	-270.635M	-270.635M	-277.950M	-383.333M	-407.652M	-442.559M	-468.241M	-475.098M	-479.314M
Current Ratio	6.74	6.74	7.14	7.69	9.86	9.10	8.30	8.20	9.37
Debt to Equity Ratio	1.75	1.75	0.99	1.46	1.63	1.95	2.27	2.47	2.72

TMDX Annual Balance Sheet (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	637.783M	497.216M	510.654M	252.294M	118.705M	146.766M	100.001M	34.794M
Cash & Cash Equivalents	488.366M	336.650M	394.812M	201.182M	25.580M	24.581M	20.092M	20.241M
Short-Term Investments	0.00	0.00	0.00	0.00	66.872M	101.061M	60.596M	0.00
Cash & Short-Term Investments	488.366M	336.650M	394.812M	201.182M	92.452M	125.642M	80.688M	20.241M
Accounts Receivable	84.282M	97.722M	63.576M	27.611M	5.934M	6.864M	6.559M	3.438M
Inventory	48.881M	46.554M	44.235M	20.605M	14.859M	11.934M	11.216M	9.277M
Total Assets	1.068B	804.076M	706.047M	277.147M	134.893M	152.026M	105.299M	42.157M
Property, Plant & Equipment	332.811M	292.451M	180.487M	24.353M	15.688M	4.754M	4.792M	3.474M
Goodwill	11.549M	11.549M	11.990M	0.00	0.00	0.00	0.00	0.00
Intangible Assets	1.948M	2.152M	2.354M	0.00	0.00	0.00	0.00	0.00
Long-Term Investments	0.00	0.00	0.00	500K	500K	0.00	500K	500K
Total Current Liabilities	89.305M	59.913M	54.934M	23.661M	23.238M	11.879M	16.115M	12.553M
Accounts Payable	10.350M	10.292M	12.717M	3.341M	6.651M	1.206M	7.247M	4.720M
Short-Term Debt	13.310M	2.727M	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	595.273M	575.473M	568.845M	89.772M	67.039M	48.135M	50.650M	46.982M
Long-Term Debt	456.381M	509.311M	506.204M	58.696M	35.197M	34.657M	34.146M	33.670M
Total Debt	469.691M	518.287M	515.946M	67.555M	43.801M	34.657M	34.146M	33.670M
Net Debt (Cash)	-18.675M	181.637M	121.134M	-133.627M	18.221M	10.076M	14.054M	13.429M
Total Shareholders' Equity	473.100M	228.603M	137.202M	187.375M	67.854M	103.891M	54.649M	-4.825M
Common Stock	750.926M	697.208M	641.106M	666.277M	510.488M	502.217M	424.134M	331.212M
Retained Earnings	-277.950M	-468.241M	-503.705M	-478.677M	-442.446M	-398.231M	-369.483M	-335.936M
Current Ratio	7.14	8.30	9.30	10.66	5.11	12.36	6.21	2.77
Debt to Equity Ratio	0.99	2.27	3.76	0.36	0.65	0.33	0.62	-6.98

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About TransMedics Group, Inc.

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.

Andover, MA

728 employees

www.transmedics.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Waleed H. Hassanein

View full financials